ERYTECH provides financial update for Q3 2013 admERY November 5, 2013 Newsroom ERYTECH announces today its cash position and its revenues for the third quarter of 2013. You Might Also Like Erytech announces trading resumption of its ordinary shares on Euronext Paris November 10, 2017 ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis February 8, 2021 ERYTECH to Webcast Presentation at Jefferies 2017 London Healthcare Conference October 9, 2018
ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis February 8, 2021
